Aegon (AGN) | Financial Analysis & Statements
Aegon Ltd. | Large-cap | Financial Services
Aegon Ltd. | Large-cap | Financial Services
Financial Overview
Latest Annual: 2024Income Metrics
Revenue
19.5B
Net Income
676.0M
3.46%
EPS (Diluted)
€0.37
Balance Sheet Metrics
Total Assets
327.4B
Total Liabilities
318.1B
Shareholders Equity
9.3B
Debt to Equity
34.15
Cash Flow Metrics
Operating Cash Flow
11.2B
Free Cash Flow
696.0M
Revenue & Profitability Trend
Aegon Income Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 19.5B | 20.1B | -21.6B | 42.5B | 37.0B |
| Cost of Goods Sold | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
| Operating Expenses | 1.8B | 1.9B | 1.4B | 2.1B | 2.6B |
| Operating Income | - | - | - | - | - |
| Pre-tax Income | 660.0M | -391.0M | 827.0M | 1.2B | -958.0M |
| Income Tax | -16.0M | -209.0M | 71.0M | 95.0M | -336.0M |
| Net Income | 676.0M | -199.0M | -540.0M | 2.0B | -135.0M |
| EPS (Diluted) | €0.37 | -€0.12 | -€0.30 | €0.94 | -€0.09 |
Income Statement Trend
Aegon Balance Sheet From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | - | - | - | - | - |
| Non-Current Assets | - | - | - | - | - |
| Total Assets | 327.4B | 301.6B | 380.7B | - | - |
| Liabilities | |||||
| Current Liabilities | - | - | - | - | - |
| Non-Current Liabilities | - | - | - | - | - |
| Total Liabilities | 318.1B | 292.0B | 369.8B | - | - |
| Equity | |||||
| Total Shareholders Equity | 9.3B | 9.6B | 10.9B | 13.6B | 24.7B |
Balance Sheet Composition
Aegon Cash Flow Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 660.0M | -346.0M | -25.0M | 2.4B | -364.0M |
| Operating Cash Flow | 11.2B | 10.0B | -38.4B | 15.8B | -1.2B |
| Investing Activities | |||||
| Capital Expenditures | -31.0M | -19.0M | -63.0M | -74.0M | -73.0M |
| Investing Cash Flow | -25.0M | -2.3B | 622.0M | -113.0M | -240.0M |
| Financing Activities | |||||
| Dividends Paid | -521.0M | -494.0M | -167.0M | -121.0M | -63.0M |
| Financing Cash Flow | -1.8B | -3.2B | -1.8B | 300.0M | -778.0M |
| Free Cash Flow | 696.0M | 748.0M | 2.6B | -1.9B | -3.0B |
Cash Flow Trend
Aegon Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
15.76
Forward P/E
6.63
Price to Book
1.27
Price to Sales
0.72
PEG Ratio
6.63
Profitability Ratios
Profit Margin
5.36%
Operating Margin
5.93%
Return on Equity
7.17%
Return on Assets
0.07%
Financial Health
Current Ratio
6.95
Debt to Equity
74.02
Beta
0.90
Per Share Data
EPS (TTM)
€0.37
Book Value per Share
€4.59
Revenue per Share
€7.83
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| agn | 9.3B | 15.76 | 1.27 | 7.17% | 5.36% | 74.02 |
| Galapagos NV | 1.6B | 51.71 | 0.57 | -6.36% | -58.83% | 0.40 |
| Pharming Group N.V | 637.6M | 57.15 | 2.88 | -6.78% | -4.40% | 55.34 |
| Avantium N.V | 113.2M | -35.65 | 1.17 | -43.03% | -127.72% | 144.79 |
| Vivoryon | 39.2M | -1.85 | 4.97 | -120.41% | 0.00% | 1.29 |
| Koninklijke Philips | 18.0B | 74.96 | 1.54 | 1.99% | 2.08% | 64.54 |
Financial data is updated regularly. All figures are in the company's reporting currency.